INTP — Integrated Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Integrated Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.254 | 1.46 | 0.183 | 0.872 | 0.067 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.02 | 0.001 | 0.028 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.391 | 1.59 | 0.384 | 1.04 | 0.246 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.065 | 2.08 | 1.75 | 1.28 | 0.755 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.465 | 3.67 | 2.19 | 2.43 | 1.11 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.663 | 0.389 | 0.409 | 0.405 | 0.269 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.867 | 0.389 | 0.409 | 0.405 | 0.269 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.402 | 3.28 | 1.78 | 2.02 | 0.838 |
Total Liabilities & Shareholders' Equity | 0.465 | 3.67 | 2.19 | 2.43 | 1.11 |
Total Common Shares Outstanding |